Outcomes and Predictors of Mortality in Perforated Versus Non-Perforated Peptic Ulcer Disease: A U.S. Nationwide Propensity-Matched Analysis, 2016–2021
Journal of Clinical Medicine · 04.06.2026 · 15 (11) · 4358
DOI: 10.3390/jcm15114358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.06.2026. Verfasst von Abdullah Sultany und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Guthrie Robert Packer Hospital, 1 Guthrie Square, Sayre, PA 18840, USA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Perforated peptic ulcer (PPU) represents a surgical emergency with substantial morbidity and mortality. Despite declining overall peptic ulcer disease (PUD) incidence, contemporary population-based data comparing outcomes between perforated and non-perforated PUD remain limited, particularly during the COVID-19 pandemic. This study aimed to characterize the clinical and economic burden of PPU and identify independent predictors of adverse outcomes.
Methods
We conducted a retrospective cohort study using the National Inpatient Sample (2016–2021), identifying 2,561,379 weighted hospitalizations for PUD. Hospitalizations were stratified by the presence (n = 207,970, 8.1%) or absence (n = 2,353,409, 91.9%) of perforation. The primary outcome was in-hospital mortality; secondary outcomes included sepsis, septic shock, acute kidney injury (AKI), prolonged length of stay (≥7 days), and high healthcare costs (≥$12,000). We performed 1:1 propensity score matching and multivariable logistic regression to assess independent predictors of adverse outcomes in the PPU cohort.
Results
After propensity matching, PPU demonstrated significantly higher mortality than non-perforated PUD (7.2% vs. 3.0%, p < 0.001), along with increased rates of sepsis (21.8% vs. 8.2%, p < 0.001), septic shock (12.9% vs. 3.5%, p < 0.001), and AKI (29.5% vs. 22.8%, p < 0.001). Nearly half (45.6%) of PPU admissions exceeded 7 days, and 69.2% incurred costs ≥$12,000. Among PPU hospitalizations, multivariable analysis identified age ≥ 65 years (aOR 5.79, 95% CI 4.60–7.28), liver cirrhosis (aOR 1.93, 95% CI 1.62–2.30), chronic heart failure (aOR 1.73, 95% CI 1.56–1.92), and concurrent COVID-19 infection (aOR 4.35, 95% CI 3.46–5.47) as independent predictors of mortality. Chronic kidney disease strongly predicted AKI (aOR 2.81, 95% CI 2.64–2.98). Mortality increased from 6.9% (2016) to 8.0% (2021) in PPU hospitalizations (p < 0.001 for trend), with higher rates observed during the 2020 to 2021 period that coincided with the COVID-19 pandemic.
Conclusions
Perforation complicates approximately 8% of hospitalized PUD cases but accounts for disproportionate mortality, sepsis, organ failure, and healthcare costs. Older age, cirrhosis, heart failure, and chronic kidney disease identify high-risk PPU patients requiring intensive monitoring and aggressive management. These findings support risk-stratified approaches focused on timely diagnosis, source control, and sepsis management to reduce the clinical and economic burden of PPU.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Guthrie Robert Packer Hospital, 1 Guthrie Square, Sayre, PA 18840, USA.
- Department of Gastroenterology and Hepatology, Guthrie Robert Packer Hospital, Sayre, PA 18840, USA.
- Department of Internal Medicine, University of Texas Health Science Center, Tyler, TX 75708, USA.
- Department of Gastroenterology, University of Kansas, Wichita, KS 67214, USA.
- Department of General and Bariatric Surgery, Guthrie Robert Packer Hospital, Sayre, PA 18840, USA.
- Division of Gastroenterology, Hepatology & Motility, School of Medicine, University of Kansas, Kansas City, KS 66160, USA.
ORCID-Profile: Abdullah Sultany, Mohamed A Omar, Rewanth Katamreddy, Dushyant Singh Dahiya, Subash Ghimire
Zitieren
APA
Sultany, A., Rao, A., Gondal, A., Theli, A., Chikatimalla, R., Omar, M. A., Katamreddy, R., Chakinala, R. C., Sultany, M. S., Dahiya, D. S., Ghimire, S., & Georgetson, M. J. (2026). Outcomes and Predictors of Mortality in Perforated Versus Non-Perforated Peptic Ulcer Disease: A U.S. Nationwide Propensity-Matched Analysis, 2016–2021. Journal of Clinical Medicine, 15(11), 4358. https://doi.org/10.3390/jcm15114358
Vancouver
Sultany A, Rao A, Gondal A, Theli A, Chikatimalla R, Omar MA, et al. Outcomes and Predictors of Mortality in Perforated Versus Non-Perforated Peptic Ulcer Disease: A U.S. Nationwide Propensity-Matched Analysis, 2016–2021. Journal of Clinical Medicine. 2026;15(11):4358. doi:10.3390/jcm15114358
BibTeX
@article{Sultany2026,
author = {Sultany, Abdullah and Rao, Adishwar and Gondal, Amlish and Theli, Abhinay and Chikatimalla, Rahul and Omar, Mohamed A and Katamreddy, Rewanth and Chakinala, Raja Chandra and Sultany, Mohammad Sulaiman and Dahiya, Dushyant Singh and Ghimire, Subash and Georgetson, Michael J},
title = {Outcomes and Predictors of Mortality in Perforated Versus Non-Perforated Peptic Ulcer Disease: A U.S. Nationwide Propensity-Matched Analysis, 2016–2021},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4358},
doi = {10.3390/jcm15114358}
}
EUVIMED